Clinical Trial Update: Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of Depigoid Birch in patients with allergic rhinitis, rhinoconjunctivitis, with or without asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis
• Asthma

Drugs mentioned

• Depigoid Birch (birch pollen allergoid)

Snippet

Sponsor: Leti Pharma GmbH | Conditions: Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma, Immunotherapy, Allergen | Phase 2 | Status: COMPLETED